Viatris Inc.
VTRS
|
$11.12
-1.77%
-1.8%
6.8M
|
Health Technology
(0.0% 1d) (-3.7% 1m) (14.2% 1y) (0.0% 2d) (0.0% 3d) (-3.3% 7d) (-100.0% volume)
Earnings Calendar: 2023-11-07
Market Cap: $ 13,340,341,520
http://www.viatris.com
Sec Filling | Patents | 35000 employees
Viatris, Inc. engages in the commercialization and manufacturing of pharmaceutical products. It also offers support services such as diagnostic clinics, educational seminars, and digital tools. The company was founded on February 14, 2019 and is headquartered in Canonsburg, PA.
education diagnostics dividends!
add to watch list Paper trade email alert is off
Press-releases
Viatris to Report First Quarter 2024 Financial Results on May 9, 2024
Published: 2024-04-16 (Crawled : 21:00) - prnewswire.com
VTRS | $11.12 -1.77% -1.8% 6.8M
|
Health Technology
| Email alert
Add to watchlist
first report financial results
Emphysema Treatment Market to Reach $8.7 Billion, Globally, by 2032 at 3.3% CAGR: Allied Market Research
Published: 2024-04-16 (Crawled : 14:00) - prnewswire.com
VTRS | $11.12 -1.77% -1.8% 6.8M
|
Health Technology
|
| O: -0.71%
H: 0.0%
C: 0.0%
NVS | $93.2 -1.28% 0.0% 1.6M
|
Health Technology
|
| O: -1.46%
H: 0.0%
C: 0.0%
PHG | $20.33 -0.39% 0.0% 740K
|
Health Technology
|
| O: -1.21%
H: 0.0%
C: 0.0%
GSK | $39.95 -1.36% 0.0% 2.4M
|
Health Technology
|
| O: -1.63%
H: 0.0%
C: 0.0%
VRNA | $16.21 2.6% 2.53% 550K
|
Health Technology
|
| O: 1.27%
H: 0.0%
C: 0.0%
reach treatment research market
Viatris Appoints Corinne Le Goff as Chief Commercial Officer
Published: 2024-04-15 (Crawled : 12:00) - prnewswire.com
VTRS | $11.12 -1.77% -1.8% 6.8M
|
Health Technology
|
| O: 0.88%
H: 1.84%
C: -0.96%
commercial
Revance to Present New DAXXIFY® Data at the American Academy of Neurology 2024 Annual Meeting
Published: 2024-04-12 (Crawled : 13:00) - biospace.com/
VTRS | $11.12 -1.77% -1.8% 6.8M
|
Health Technology
|
| O: -0.17%
H: 0.17%
C: -1.9%
RVNC | $3.82 -3.78% -3.93% 2.4M
|
Health Technology
|
| O: -2.01%
H: 1.37%
C: -5.92%
daxxify neurology meeting
Central Nervous System (CNS) Stimulant Drugs Market size is set to grow by USD 6.48 billion from 2023-2027, Rise in incidence of CNS disorders boost the market, Technavio
Published: 2024-04-10 (Crawled : 09:00) - prnewswire.com
ALPMF | $9.48 43.47% 1.7K
|
Health Technology
|
| O: -100.0%
H: NaN%
C: Infinity%
SNYNF | $92.966 -2.18% 630
|
Health Technology
|
| O: -0.01%
H: 0.0%
C: 0.0%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: -1.67%
H: 0.0%
C: 0.0%
ALPMY | $9.2715 -1.11% 500K
|
Manufacturing
|
| O: -0.29%
H: 0.0%
C: -1.97%
VTRS | $11.12 -1.77% -1.8% 6.8M
|
Health Technology
|
| O: -0.6%
H: 1.03%
C: 0.52%
TMO | $554.55 -0.6% 0.0% 1M
|
Health Technology
|
| O: -2.01%
H: 0.0%
C: 0.0%
NVS | $93.2 -1.28% 0.0% 1.6M
|
Health Technology
|
| O: -1.16%
H: 0.0%
C: 0.0%
SNY | $45.81 -0.93% -0.94% 1.4M
|
Health Technology
|
| O: -0.32%
H: 0.0%
C: 0.0%
JAZZ | $108.92 -1.79% -1.83% 540K
|
Health Technology
|
| O: -1.71%
H: 0.57%
C: 0.37%
disorders system set market
Eczema Therapeutics Market size is set to grow by USD 5.81 bn from 2024-2028,high prevalence of atopic dermatitis boost the market- Technavio
Published: 2024-04-08 (Crawled : 18:00) - prnewswire.com
SNYNF | $92.966 -2.18% 630
|
Health Technology
|
| O: 2.24%
H: 0.0%
C: -0.8%
AZNCF | $135.94 -4.19% 770
|
Health Technology
|
| O: -3.43%
H: 6.21%
C: 6.21%
VTRS | $11.12 -1.77% -1.8% 6.8M
|
Health Technology
|
| O: -0.25%
H: 1.1%
C: -0.17%
NVS | $93.2 -1.28% 0.0% 1.6M
|
Health Technology
|
| O: -0.05%
H: 0.43%
C: -0.27%
BMY | $48.26 -0.52% 0.04% 12M
|
Health Technology
|
| O: -0.08%
H: 0.04%
C: -0.35%
BHC | $8.74 1.28% 0.11% 2.5M
|
Health Technology
|
| O: 0.38%
H: 0.0%
C: -7.27%
ABBV | $162.54 0.54% 0.0% 4.8M
|
Health Technology
|
| O: 0.77%
H: 1.63%
C: 0.35%
SNY | $45.81 -0.93% -0.94% 1.4M
|
Health Technology
|
| O: 0.84%
H: 0.0%
C: 0.0%
AZN | $68.27 -0.67% -0.67% 3.8M
|
Health Technology
|
| O: 0.18%
H: 0.3%
C: 0.19%
eczema dermatitis set therapeutics market
Contraceptive Market Projected to Reach $119.89 billion by 2030 - Exclusive Report by 360iResearch
Published: 2024-04-03 (Crawled : 02:00) - prnewswire.com
VTRS | $11.12 -1.77% -1.8% 6.8M
|
Health Technology
|
| O: -0.42%
H: 2.78%
C: 1.09%
SNY | $45.81 -0.93% -0.94% 1.4M
|
Health Technology
|
| O: 0.69%
H: 0.0%
C: 0.0%
report reach contraceptive market
Ocuphire Announces the U.S. Commercial Launch of RYZUMVl™ (Phentolamine Ophthalmic Solution 0.75%) by its Partner Viatris
Published: 2024-04-01 (Crawled : 12:00) - globenewswire.com
VTRS | $11.12 -1.77% -1.8% 6.8M
|
Health Technology
|
| O: 0.84%
H: 0.0%
C: -0.25%
OCUP | $1.75 -0.57% -0.57% 110K
|
Health Technology
|
| O: 1.0%
H: 10.4%
C: 10.4%
solution commercial ryzumvl apx3330
Idorsia and Viatris successfully close the transaction for the global research and development collaboration
Published: 2024-03-18 (Crawled : 06:00) - globenewswire.com
VTRS | $11.12 -1.77% -1.8% 6.8M
|
Health Technology
|
| O: -0.59%
H: 0.59%
C: -0.93%
research global collaboration
Scott+Scott Attorneys at Law LLP & Hedin Hall LLP Announce Notice of Class Action and Proposed Settlement to All Who Purchased or Acquired Shares of Viatris Inc. Pursuant to a November 2020 Merger of Mylan N.V. and Upjohn, Inc. to Form Viatris
Published: 2024-03-11 (Crawled : 14:00) - prnewswire.com
VTRS | $11.12 -1.77% -1.8% 6.8M
|
Health Technology
|
| O: -0.82%
H: 0.7%
C: -1.56%
acquired
Last 15 days Sec forms
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 58% | 42% |
Top 10 Gainers
WISA 4 | $6.06 246.29% 71.12% 200M
|
Electronic Technology
VIAO | $0.265 -13.96% 35.85% 960K
|
Electronic Technology
JAGX | $0.178 49.83% 33.26% 600M
|
Health Technology
SXTC | $1.68 43.59% 30.36% 34M
|
Health Technology
DYNT | $0.531 43.36% 30.24% 22M
|
Health Technology
KA | $0.4796 41.06% 29.11% 5.3M
|
Manufacturing
PALI | $5.86 40.87% 29.01% 29M
|
Manufacturing
CLNN | $0.319 -3.74% 28.75% 6.3M
|
BSGM | $1.52 38.18% 27.63% 3.3M
|
Health Technology
MCBC | $13.67 37.66% 27.36% 2.2M
|
Finance
Last 48 Hours Insiders Buying
KFS P 481 | $8.6 1.06% 0.0% 15K
|
Finance
|
20:30
AINC | $4.83 -1.43% 1.45% 98K
|
Finance
|
20:30
RVP P 3587 | $1.065 -1.39% 0.47% 49K
|
Health Technology
|
17:00
TPL P 12 | $586.93 0.52% 0.0% 50K
|
Miscellaneous
|
16:01
HNRA | $2.76 16.95% -1.81% 400K
|
n/a
|
15:02
TGEN | $0.67 39.71% 16K
|
Utilities
|
14:30
RMCF | $3.6492 -7.2% 9.2K
|
Consumer Non-Durables
|
20:10